Galena Biopharma (GALE) Phase 2 Clinical Trial of NeuVax Open for Enrollment and Screening Patients
Tweet Send to a Friend
Galena Biopharma, Inc. (NASDAQ: GALE) announced that the NeuVax™ (nelipepimut-S) Phase 2 clinical trial entitled VADIS: Phase 2 trial of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
